ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,512Medicare Part D Prescriptions Filled, Including Refills

Rank: 223 out of 1206

$484K Total Retail Price of All Prescriptions

Rank: 179 out of 1206

381 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,698 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LISINOPRIL 281 188 1 4
FUROSEMIDE 281 197 1 5
SIMVASTATIN 280 149 3 1
LEVOTHYROXINE SODIUM 277 239 4 2
WARFARIN SODIUM 265 180 5 8
OMEPRAZOLE 250 200 6 3
HYDROCODONE-ACETAMINOPHEN 238 191 S3 7 7
METOPROLOL TARTRATE 219 157 8 9
METFORMIN HCL 159 93 9 10
CITALOPRAM HBR 146 86 10 16
AMLODIPINE BESYLATE 132 119 11 6
ZOLPIDEM TARTRATE 130 117 12 25
POTASSIUM CHLORIDE 114 95 13 12
TRAZODONE HCL 102 36 14 37
DONEPEZIL HCL 102 80 14 29
RISPERIDONE 99 64 16 74
MIRTAZAPINE 97 84 17 50
QUETIAPINE FUMARATE 93 59 18 79
TRAMADOL HCL 88 66 19 17
DIOVAN 85 54 20 57
NAPROXEN 81 54 21 105
METOPROLOL SUCCINATE 80 57 22 15
PANTOPRAZOLE SODIUM 79 64 23 54
ESCITALOPRAM OXALATE 78 54 24 86
CARVEDILOL 77 50 25 32
FAMOTIDINE 76 53 26 65
RANITIDINE HCL 74 36 27 23
BUSPIRONE HCL 71 48 28 110
LOSARTAN POTASSIUM 71 71 28 20
SERTRALINE HCL 70 66 30 22
ATENOLOL 67 54 31 14
BENZTROPINE MESYLATE 65 33 R 32 180
NAMENDA 65 54 32 36
ROPINIROLE HCL 65 31 32 77
PAROXETINE HCL 64 40 35 53
HYDROCHLOROTHIAZIDE 63 42 36 11
FENTANYL 63 54 S2 36 51
AZITHROMYCIN 63 48 36 46
ATORVASTATIN CALCIUM 62 51 39 13
LANTUS 61 53 40 38
CYCLOBENZAPRINE HCL 61 15 R 40 80
LEVOFLOXACIN 60 43 42 78
GABAPENTIN 57 44 43 18
DIGOXIN 56 50 44 43
CEPHALEXIN 56 42 44 62
OXYCODONE-ACETAMINOPHEN 56 28 S2 44 106
LACTULOSE 56 49 44 124
SPIRONOLACTONE 53 39 48 41
TAMSULOSIN HCL 52 39 49 26
OXYBUTYNIN CHLORIDE ER 52 40 49 119
OXYBUTYNIN CHLORIDE 52 51 49 68
VERAPAMIL ER 51 34 52 97
IPRATROPIUM-ALBUTEROL 50 31 53 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.